NIMBUS®

The Company’s patented technology, NIMBUS®, employs a family of advanced antimicrobial polymers that destroy bacteria at the cellular level, thereby eliminating the risk of developing drug resistance. Unlike any other microbicide on the market today, the NIMBUS technology works by creating a permanent bond with a multitude of substrates (without leaching) and is less than 10% the cost of silver-based antimicrobials. NIMBUS is highly effective, including against methicillin-resistant Staphylococcus aureus (“MRSA”) and vancomycin-resistant Enterococcus (“VRE”), two of the most significant antibiotic-resistant organisms responsible for hospital infections.

MultiStat™

MultiStat™ is a family of technologies and compounds called Matrix Metalloproteinase Inhibitors (MMPIs), that modern research has shown plays a key role in numerous skins conditions, and boasts a broad spectrum of uses including cosmetic and pharmaceutical (consumer, medical, and military).